Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.45 |
| ▸ | APAF1 | O14727 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 11/20 | 0.42 |
| ▸ | ESR1 | P03372 | 6/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | AKT1 | P31749 | 1/20 | 0.40 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.40 |
| ▸ | TUBB | P07437 | 1/20 | 0.40 |
| ▸ | YES1 | P07947 | 1/20 | 0.40 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.40 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.40 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.40 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.40 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.40 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.40 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.40 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28525073 | 0.79 | MAOB (0.40) | MAPTCYP19A1MEN1KMT2A | |
| SCHEMBL9244468 | 0.79 | FADS1 (0.42) | CYP19A1TDP1 | |
| SCHEMBL9164472 | 0.79 | AKT1 (0.40) | MAPTSIRT1POLBCYP19A1AKT1 | |
| SCHEMBL120709 | 0.78 | MEN1 (0.48) | MAPTSIRT1POLBCYP19A1ADORA3 | |
| SCHEMBL8207399 | 0.77 | MEN1 (0.47) | MAPTSIRT1POLBCYP19A1ADORA3 | |
| SCHEMBL28985350 | 0.75 | ALDH1A1 (0.33) | CYP3A4CA12HSD17B10 | |
| SCHEMBL3428777 | 0.75 | LMNA (0.52) | MAPTPOLBCYP19A1CYP3A4NPC1 | |
| SCHEMBL10590171 | 0.75 | CYP19A1 (0.39) | POLBCYP19A1MEN1KMT2AKDM4E | |
| SCHEMBL6543433 | 0.73 | HSD17B10 (0.45) | MAPTSIRT1APAF1POLBESR2 | |
| SCHEMBL6175110 | 0.73 | KMT2A (0.46) | MAPTPOLBMEN1KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116390704-A | Composition for whitening and/or lightening keratin materials | 莱雅公司 | 2023-07-04 | — | — | CN | claimed |
| EP-1649901-B1 | Light screening composition comprising a dibenzoylmethane derivative, a lipophilic amide and a compound capable of accepting energy from the excited triplet state of dibenzoylmethane; process for photostabilsation | OREAL (FR) | 2018-11-28 | — | — | EP | claimed |
| EP-2923690-A1 | COMPOSITION FOR STABILISING PHOTOSENSITIVE COMPOUNDS | Sensient Cosmetic Technologies (FR) | 2015-09-30 | — | — | EP | claimed |
| EP-1649902-B1 | Light screening composition comprising a dibenzoylmethane derivative, an arylalkyl benzoat derivative and a compound capable of accepting energie from the excited triplet state of dibenzoylmethane; process of photostabilisation | OREAL (FR) | 2012-07-11 | — | — | EP | claimed |
| EP-1649900-B1 | Light screening composition comprising a derivative of dibenzoylmethane, a bis-resorcinyl triazine and a compound capable of accepting energy of the excited triplet state of dibenzoylmethane; process for photostabilisation | OREAL (FR) | 2012-04-18 | — | — | EP | claimed |
| US-20100254923-A1 | COMPOSITION AND PROCESS FOR PROTECTING CELLULAR TARGETS FROM AGING AND PHOTODAMAGE | L'ORÉAL (FR) | 2010-10-07 | — | — | US | claimed |
| EP-1649900-A2 | Light screening composition comprising a derivative of dibenzoylmethane, a bis-resorcinyl triazine and a compound capable of accepting energy of the excited triplet state of dibenzoylmethane; process for photostabilisation | L'OREAL (FR) | 2006-04-26 | — | — | EP | claimed |
| EP-1649902-A2 | Light screening composition comprising a dibenzoylmethane derivative, an arylalkyl benzoat derivative and a compound capable of accepting energie from the excited triplet state of dibenzoylmethane; process of photostabilisation | L'OREAL (FR) | 2006-04-26 | — | — | EP | claimed |
| EP-1649901-A2 | Light screening composition comprising a dibenzoylmethane derivative, a lipophilic amide and a compound capable of accepting energy from the excited triplet state of dibenzoylmethane; process for photostabilsation | L'OREAL (FR) | 2006-04-26 | — | — | EP | claimed |
| EP-3937896-B1 | SUNSCREEN COMPOSITIONS COMPRISING BUTYL METHOXYDIBENZOYLMETHANE, TRIAZINE DERIVATIVES AND PHOTOSTABILIZER | BASF SE (DE) | 2025-01-15 | — | — | EP | disclosed |
| CN-119300802-A | Personal care compositions for sensitive skin and methods of use thereof | 高德美控股有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-116390704-A | Composition for whitening and/or lightening keratin materials | 莱雅公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-116390704-A | Composition for whitening and/or lightening keratin materials | 莱雅公司 | 2023-07-04 | — | — | CN | disclosed |
| US-20220226215-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | L'OREAL (FR) | 2022-07-21 | — | — | US | disclosed |
| US-6160124-A | Method for treating or preventing arteriosclerosis | JAPAN TOBACCO INC. (JP) | 2000-12-12 | — | — | US | disclosed |
| US-6057343-A | HAVE SUPERIOR HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIONS AND ARE USEFUL FOR THE TREATMENT OF DIABETES AND THE COMPLICATIONS THEREOF, AS WELL AS THERAPEUTIC AGENTS FOR RELATED DISEASES SUCH AS HYPERLIPIDEMIA | JAPAN TOBACCO, INC. (JP) | 2000-05-02 | — | — | US | disclosed |
| WO-2000022037-A1 | SOLID, SHAPED AND COLORED WAX ARTICLES | CLARIANT FINANCE (BVI) LIMITED (VG) | 2000-04-20 | — | — | WO | disclosed |
| US-6037359-A | ARTERIOSCLEROSIS PREVENTION; ANTIDIABETIC AGENTS; ANTILIPEMIC AND HYPOGLYCEMIC AGENTS | JAPAN TOBACCO, INC. (JP) | 2000-03-14 | — | — | US | disclosed |
| US-5939445-A | ISOXAZOLIDINEDIONES COMPOUNDS AS HYPOGLYCEMIC AGENTS AND TREATMENT OF ARTERIOSCLEROSIS | JAPAN TOBACCO, INC. (JP) | 1999-08-17 | — | — | US | disclosed |
| US-5728720-A | HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; TREATMENT OF DIABETES | JAPAN TOBACCO INC. (JP) | 1998-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100254923-A1 | COMPOSITION AND PROCESS FOR PROTECTING CELLULAR TARGETS FROM AGING AND PHOTODAMAGE | RAD52, MMS19, XPA | MAPT 1298/4885SIRT1 107/4885APAF1 1868/4885 |
| US-20220226215-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING A DIBENZOYLMETHANE DERIVATIVE, A MEROCYANINE COMPOUND AND A COMPOUND CAPABLE OF ACCEPTING THE TRIPLET EXCITED LEVEL ENERGY OF THE DIBENZOYLMETHANE COMPOUND | ERCC5, DDT, ERCC1 | MAPT 168/4885SIRT1 254/4885APAF1 3401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.